Table II.
Patients N (%) |
Mean | ||
---|---|---|---|
Demographic data |
Gender | ||
• Male • Female |
101 (61.5) 63 (38.4) |
||
Age | 62.84 | ||
• 0-60 years • ≥ 60 years |
56 (34.1) 108 (65.9) |
||
Clinical features |
Tumour site | ||
• Pharynx-larynx • Neck-thyroid-salivary glands • Oral cavity |
64 (39.1) 58 (35.4) 32 (19.5) 10 (6.1) |
||
Stage | |||
• Low (0-I-II) • High (III-IV) |
52 (36.8) 89 (63.2) |
||
Previous therapies | |||
• No • Yes |
114 (69.5) 50 (30.5) |
||
ASA | |||
• 1 • 2 • 3 • 4 |
5 (3.1) 59 (36.0) 86 (52.5) 14 (8.6) |
||
Surgical complexity | |||
• Minor • Moderate • Major |
1 (0.6%) 56 (34.2) 107 (65.2) |
||
Post-operative complications | |||
• No • Yes |
138 (84.1) 26 (15.9) |
||
Hospital stay | 11.46 | ||
• ≤ 5 days • 6-20 days • ≥ 21 days |
63 (38.5) 77 (46.9) 24 (14.6) |
||
Post-op analgesic therapy | |||
• Opioids • Opioids+NSAIDs/paracetamol • NSAIDs |
27 (16.5) 121 (73.7) |
||
16 (9.8) | |||
Analgesic therapy at discharge | |||
• No • Yes • Data not available |
69 (42.0) 90 (54.9) 5 (3.1) |